Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Lyndra Therapeutics received early financing of $5.9M on 2016-07-13.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $5.9M | 07/2016 |
| Series A | $23M | 04/2017 |
| Series B | $60.9M | 02/2019 |
| Grant | $13M | 07/2019 |
| Series C | $60.5M | 06/2021 |
| Investors | Security type |
|---|---|
| Polaris Partners | Series A |
| GF Securities Co Ltd | Series A |
| Healthlink Capital | Series A |
| Suffolk Equity Partners | Series A |
| Quark Venture | Series A |
| Partners HealthCare | Series A |
| Yonghua Capital | Series A |
| Polaris Partners | Series B |
| GF Securities Co Ltd | Series B |
| Gilead Sciences | Series B |
| Healthlink Capital | Series B |
| Suffolk Equity Partners | Series B |
| Orient Life | Series B |
| Quark Venture | Series B |
| Yonghua Capital | Series B |
| Invus | Series B |
| HOPU Investment Management Company | Series B |
| Fujifilm | Series B |
| Partners HealthCare | Series B |
| Bill & Melinda Gates Foundation | Series B |
| Bill & Melinda Gates Foundation | Grant |
| THE CATALYTIC IMPACT FOUNDATION (CIF) | Series C |
| Polaris Partners | Series C |
| Limitless Ventures | Series C |
| Yipinhong Pharmacy | Series C |
| Invus | Series C |
| Impactassets Inc | Series C |
| HOPU Investment Management Company | Series C |
| Mass General Brigham Ventures | Series C |
| Gilead Sciences | Series C |
| Quark Venture | Series C |
| AIG Investments | Series C |
Zippia gives an in-depth look into the details of Lyndra Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Lyndra Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Lyndra Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Lyndra Therapeutics. The data presented on this page does not represent the view of Lyndra Therapeutics and its employees or that of Zippia.
Lyndra Therapeutics may also be known as or be related to Lyndra, Lyndra Therapeutics, Lyndra Therapeutics Inc, Lyndra Therapeutics, Inc. and Lyndra, Inc.